# All Eyes on Allergan: Drug Company’s Unprecedented Move Raises Questions for Patent and Drug Law (Part II)
> **Legal Sidebar** · 2017-10-12 · `LSB10010`
## Report
- **CRS ID:** LSB10010
- **Series:** Legal Sidebar
- **Publication date:** 2017-10-12
## Documents
- [PDF](https://www.everycrsreport.com/files/2017-10-12_LSB10010_19938baab152f257d82a592a68c47f5dd1a8df7e.pdf)
- [HTML](https://www.everycrsreport.com/files/2017-10-12_LSB10010_19938baab152f257d82a592a68c47f5dd1a8df7e.html)
---
*AI Analytics · CC0 1.0*